Innovent/GenFleet Score China’s First KRAS G12C Inhibitor Approval

Homegrown Competition Looming

first to hit the line
Innovent/GenFlee hit finish line for China's first approved KRAS G12C inhibitor • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from China

More from Focus On Asia